Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deuterated Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed method for selective benzylic deuteration offers high purity and scalability for API manufacturing, reducing costs and improving supply chain reliability for deuterated drugs.
Patent CN114349585A details a copper-catalyzed asymmetric synthesis of chiral alpha-deuterated pyrrolidines using D2O, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112281182B reveals mild electrochemical method for high-purity deuterated aromatics using heavy water, offering cost-effective supply chain solutions.
Patent CN114369081B reveals silver-catalyzed deuteration for OLED materials, offering high purity and cost-effective manufacturing solutions for electronic chemical supply chains.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Novel Pd-catalyzed route for high-purity deuterated intermediates. Cost-effective, scalable manufacturing for pharmaceutical applications using aryl sulfur salts.
Advanced synthesis method for high-purity deuterated celecoxib intermediate offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN110590487A reveals Ru-catalyzed deuteration. Offers high purity and supply chain stability for pharmaceutical intermediates manufacturing and global analysis.